Zhejiang Shouxiangu Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the breeding, cultivation, processing, and sale of Chinese medicinal herbs in China and internationally. The company offers ganoderma lucidum spore powder, dendrobium officinale, and saffron products, as well as health and ordinary food, agricultural and sideline products, personal and skincare, and traditional Chinese medicines under the Shouxiangu brand name. It is also involved in the wholesale and retail; technology research and development; and real estate business. The company was founded in 1909 and is headquartered in Jinhua, China.
Frequently asked questions
What sector does Zhejiang Shouxiangu Pharm Co (603896) operate in?
Zhejiang Shouxiangu Pharm Co belongs to the Consumer Staples sector and operates in the Biotechnology industry.
What is Zhejiang Shouxiangu Pharm Co (603896) current stock price?
As of the latest data, Zhejiang Shouxiangu Pharm Co stock price is CN¥14.82, with a previous close of CN¥14.69. Zhejiang Shouxiangu Pharm Co gained CN¥0.13 in the last trading session, representing a 0.88% increase.
What is Zhejiang Shouxiangu Pharm Co (603896) current market capitalization?
Zhejiang Shouxiangu Pharm Co market cap is approximately 2.94 billion.
What is Zhejiang Shouxiangu Pharm Co (603896) Earnings Per Share (EPS)?
The trailing EPS is -CN¥0.05.
What is Zhejiang Shouxiangu Pharm Co (603896) EBITDA?
Zhejiang Shouxiangu Pharm Co EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 14.39 million.
Does Zhejiang Shouxiangu Pharm Co (603896) pay dividends?
No. Zhejiang Shouxiangu Pharm Co does not pay a dividend.
What is Zhejiang Shouxiangu Pharm Co (603896) beta (volatility) score?
Zhejiang Shouxiangu Pharm Co has a beta of 0.258, indicating lower volatility than the overall market.
